Calreticulin Mutation in JAK2V617F Negative Myeloproliferative Neoplasms - The Beaumont Experience

被引：0
|
作者：
Sikdar, Soma [1 ]
Prada, Anne [1 ]
Crisan, Domnita [1 ]
机构：
[1] William Beaumont Hosp, Royal Oak, MI 48072 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1505
引用
收藏
页码：378A / 378A
页数：1
相关论文
共 50 条
  • [1] Calreticulin Mutation in JAK2V617F Negative Myeloproliferative Neoplasms - The Beaumont Experience
    Sikdar, Soma
    Prada, Anne
    Crisan, Dominita
    LABORATORY INVESTIGATION, 2015, 95 : 378A - 378A
  • [2] JAK2V617F mutation and thrombosis in the myeloproliferative neoplasms
    Demirkan, F.
    Kalkan, S.
    Kahraman, S.
    Tunali, S.
    Katgi, A.
    Piskin, O.
    Ozcan, M. A.
    Ozsan, H. G.
    Undar, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 890 - 890
  • [3] Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation
    Guy, Alexandre
    Helzy, Khalil
    Mansier, Olivier
    Bordet, Jean-Claude
    Riviere, Etienne
    Fiore, Mathieu
    James, Chloe
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (02)
  • [4] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
    Sun, Tiantian
    Zhang, Lei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381
  • [5] The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms
    Sahin, Ezgi
    Yonal-Hindilerden, Ipek
    Hindilerden, Fehmi
    Aday, Aynur
    Nalcaci, Meliha
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 150 - 165
  • [6] Underlying mechanisms of the JAK2V617F mutation in the pathogenesis of myeloproliferative neoplasms
    Mullally, A.
    PATHOLOGE, 2016, 37 : 175 - 179
  • [7] The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
    Holmstrom, M. O.
    Hjortso, M. D.
    Ahmad, S. M.
    Met, O.
    Martinenaite, E.
    Riley, C.
    Straten, P.
    Svane, I. M.
    Hasselbalch, H. C.
    Andersen, M. H.
    LEUKEMIA, 2017, 31 (02) : 495 - 498
  • [8] The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
    M O Holmström
    M D Hjortsø
    S M Ahmad
    Ö Met
    E Martinenaite
    C Riley
    P Straten
    I M Svane
    H C Hasselbalch
    M H Andersen
    Leukemia, 2017, 31 : 495 - 498
  • [9] Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
    Holl, Kristin
    Chatain, Nicolas
    Krapp, Susanne
    Baumeister, Julian
    Maie, Tiago
    Schmitz, Sarah
    Scheufen, Anja
    Brock, Nathalie
    Koschmieder, Steffen
    Moreno-Andres, Daniel
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms
    Singh, Kanwaljeet
    Sazawal, Sudha
    Chhikara, Sunita
    Mahapatra, Manoranjan
    Saxena, Renu
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (03) : 371 - 374
12345